Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette‐Guerin and with or without irradiation in operable breast cancer a prospective randomized trial

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Cancer

• Publication date

  1984-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19840201)53:3<384::AID-CNCR2820530303>3.0.CO;2-GPMID 6362814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental basis of adjuvant chemotherapy.

  1983cited by this paper
• Adjuvant chemotherapy for breast cancer.

  1981cited by this paper
• Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of bacillus calmette‐guerin (MER) in advanced breast cancer: A randomized trial by the piedmont oncology association

  1981cited by this paper
• Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC)

  1979cited by this paper
• Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report.

  1979cited by this paper
• Adjuvant chemotherapy of breast cancer

  1979cited by this paper
• Prognostic factors in metastatic breast cancer treated with combination chemotherapy.

  1979cited by this paper
• Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer

  1978cited by this paper
• Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancer.

  1978cited by this paper
• A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

  1978cited by this paper
• Surgical adjuvant chemotherapy. Results with one short course with cyclophosphamide after mastectomy for breast cancer

  1978cited by this paper
• Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.

  1978cited by this paper
• Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.

  1976cited by this paper
• Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L‐phenylalanine mustard

  1976cited by this paper
• Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer

  1975cited by this paper
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper
• Response of advanced breast carcinoma to the combination of the antimetabolite, Methotrexate, and the alkylating agent, thio-TEPA.

  1963cited by this paper

• Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells

  2021cites this paper
• Immunotherapy and targeted therapy combinations in metastatic breast cancer.

  2019cites this paper
• Estrogen deprivation triggers an immunosuppressive phenotype in breast cancer cells

  2019cites this paper
• Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis

  2019cites this paper
• Long-Term Outcome for Patients with Isolated Supraclavicular Nodal Recurrence After Mastectomy and Doxorubicin-Based Chemotherapy for Breast Cancer

  2015cites this paper
• Role of Postmastectomy Radiation for DCIS

  2015cites this paper
• Progress and controversies: Radiation therapy for invasive breast cancer

  2014cites this paper
• Postmastectomy Radiation Therapy: An Overview for the Practicing Surgeon

  2013cites this paper
• Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience

  2013cites this paper
• Trial watch

  2012cites this paper
• Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and doxorubicin-based chemotherapy for breast cancer.

  2011cites this paper
• Low locoregional recurrence rates in patients treated after 2000 with doxorubicin based chemotherapy, modified radical mastectomy, and post-mastectomy radiation.

  2010cites this paper
• Radiation therapy for operable breast cancer

  2008cites this paper
• Radiation as an Adjunct to Surgery

  2008cites this paper
• Adjuvant chemotherapy for high-risk operable breast cancer.

  2007cites this paper
• Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer

  2007cites this paper
• African‐American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin‐based chemotherapy

  2006cites this paper
• Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients

  2006cites this paper
• Feasibility of postmastectomy radiation therapy after TRAM flap breast reconstruction

  2006cites this paper
• Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.

  2005cites this paper
• The role of post-operative radiotherapy in the treatment of operable breast cancer

  2005cites this paper
• Vaccine Therapy for Breast and Ovarian Cancers

  2004cites this paper
• Is breast cancer survival improving?

  2004cites this paper
• Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer

  2004cites this paper
• Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival.

  2003cites this paper
• Changes i n t he 2 003 A merican J oint C ommittee o n C ancer Staging f or B reast C ancer D ramatically A ffect S tage-Specific Survival

  2003cites this paper
• Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy.

  2003cites this paper
• A Phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma

  2003cites this paper
• Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.

  2003cites this paper
• Adjuvant radiation therapy following mastectomy for breast cancer

  2002cites this paper
• Outcome with Postmastectomy Radiation with Transverse Rectus Abdominis Musculocutaneous Flap Breast Reconstruction

  2002cites this paper
• The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy.

  2001cites this paper
• Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation.

  2001cites this paper
• Does treatment at the time of locoregional failure of breast cancer alter prognosis?

  2001cites this paper
• La radiothérapie locorégionale postmastectomie pour cancer du sein: analyse de la littérature

  2000cites this paper
• Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.

  2000cites this paper
• [Postmastectomy locoregional radiotherapy for breast cancer: literature review].

  2000cites this paper
• Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

  2000cites this paper
• Adjuvant systemic therapy for primary breast cancer.

  1999cites this paper
• Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue.

  1999cites this paper
• Radiotherapy following mastectomy: indication and contraindication of chest wall irradiation.

  1999cites this paper
• Integration of Systemic Chemotherapy in the Management of Primary Breast Cancer.

  1998cites this paper
• [Hematopoietic growth factors, a dilemma for the clinician].

  1997cites this paper
• Postmastectomy radiation

  1997cites this paper
• Les facteurs de croissance hématopoïétiques, un dilemme pour le clinicien

  1997cites this paper
• Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.

  1997cites this paper
• Carcinoma in Axillary Nodes in Women with Unknown Primary Site—Results of Breast‐Conserving Therapy

  1996cites this paper
• Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.

  1995cites this paper
• Post-mastectomy radiotherapy: is it cure after all?

  1994cites this paper
• Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast Cancer

  1994cites this paper
• Long-term efficacy and late sequelae of Doxorubicin­ containing adjuvant therapy for breast cancer : MD Anderson Cancer Center studies

  1994cites this paper
• Management of locally recurrent breast cancer

  1993cites this paper
• Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node‐positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors

  1993cites this paper
• Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer.

  1992cites this paper
• Adjuvant chemotherapy of axillary lymph-node-positive breast cancer.

  1992cites this paper
• Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5‐year results from the nishi‐nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

  1992cites this paper
• Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin‐containing adjuvant therapy

  1992cites this paper
• Surgical adjuvant chemotherapy for breast cancer: a comparison of CMF and CAF regimens.

  1991cites this paper
• Medical management of early-stage breast cancer.

  1991cites this paper
• Immunotherapy of breast cancer: a review of the development of cell-specific therapy.

  1991cites this paper
• Current Status of Adjuvant Therapy of Early Breast Cancer

  1991cites this paper
• Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?

  1990cites this paper
• Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma.

  1989cites this paper
• The changing role of radiation therapy in the treatment of primary breast cancer.

  1989cites this paper
• Ten‐Year Results of FAC Adjuvant Chemotherapy Trial in Breast Cancer

  1989cites this paper
• The case in developing countries for routine postoperative radiotherapy after mastectomy in patients with histologically positive axillary nodes.

  1989cites this paper
• Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: evaluation of the role of postoperative radiotherapy.

  1989cites this paper
• Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.

  1988cites this paper
• Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs

  1988cites this paper
• Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy.

  1988cites this paper
• Postoperative immunochemotherapy (BCG + 5-FU) in advanced gastric cancer.

  1988cites this paper
• The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.

  1987cites this paper
• Review: Adjuvant Chemotherapy of Solid Tumors

  1987cites this paper
• Is radiation therapy in conjunction with mastectomy indicated for the treatment of operable breast cancer?

  1987cites this paper
• Adjuvant chemotherapy of solid tumors.

  1987cites this paper
• Immunobiology of Human Breast Cancer

  1987cites this paper
• Comparative study of long-term effects of surgical excision and excision combined with radiotherapy or chemotherapy in breast cancer: an analysis of 192 cases.

  1987cites this paper
• Adjuvant chemo‐lmmunotherapy in stage II carcinoma of the breast

  1986cites this paper
• Clinical trials of the treatment of minimal residual tumours.

  1986cites this paper
• Breast tumours: adjuvant radiotherapy trials.

  1986cites this paper
• Is BCG and "orphan" drug suffering from chemotherapists' overkill?

  1986cites this paper
• Biologic response modifiers as adjuncts to other therapeutic modalities.

  1986cites this paper
• Adjuvant systemic therapy for resectable breast cancer.

  1985cites this paper
• FAC + BCG as adjuvant therapy in breast cancer: an 8-year update.

  1984cites this paper
• Significance of drug dose, timing and radiotherapy in adjuvant therapy of breast cancer.

  1984cites this paper